Jörg Hauptmann

489 total citations
13 papers, 423 citations indexed

About

Jörg Hauptmann is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jörg Hauptmann has authored 13 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Jörg Hauptmann's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Peptidase Inhibition and Analysis (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jörg Hauptmann is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Peptidase Inhibition and Analysis (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jörg Hauptmann collaborates with scholars based in Germany, France and Czechia. Jörg Hauptmann's co-authors include Jörg Stürzebecher, Torsten Steinmetzer, Brigitte Kaiser, P Wikström, Dagmar Prasa, F Markwárdt, Wolfram Bode, Milton T. Stubbs, Luis Moroder and Andreas Bergner and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Biochemistry and Biochemical Pharmacology.

In The Last Decade

Jörg Hauptmann

13 papers receiving 388 citations

Peers

Jörg Hauptmann
Valeria Chu United States
Maria T. Stranieri United States
Adel M. Naylor-Olsen United States
Lawrence J. Mersinger United States
Gary R. Sitko United States
Trelia J. Craft United States
Leo Alig Switzerland
Valeria Chu United States
Jörg Hauptmann
Citations per year, relative to Jörg Hauptmann Jörg Hauptmann (= 1×) peers Valeria Chu

Countries citing papers authored by Jörg Hauptmann

Since Specialization
Citations

This map shows the geographic impact of Jörg Hauptmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Hauptmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Hauptmann more than expected).

Fields of papers citing papers by Jörg Hauptmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Hauptmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Hauptmann. The network helps show where Jörg Hauptmann may publish in the future.

Co-authorship network of co-authors of Jörg Hauptmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Hauptmann. A scholar is included among the top collaborators of Jörg Hauptmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Hauptmann. Jörg Hauptmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hauptmann, Jörg, et al.. (2002). Influence of Structural Variations in Peptidomimetic 4-Amidinophenylalanine-Derived Thrombin Inhibitors on Plasma Clearance and Biliary Excretion in Rats. Pharmaceutical Research. 19(7). 1027–1033. 10 indexed citations
2.
Steinmetzer, Torsten, et al.. (2001). Structure-Activity Relationships of New NAPAP-Analogs. Journal of enzyme inhibition. 16(3). 241–249. 10 indexed citations
3.
Kamm, Walter, Jörg Hauptmann, Jörg Stürzebecher, et al.. (2001). Transport of Peptidomimetic Thrombin Inhibitors with a 3-Amidino-Phenylalanine Structure: Permeability and Efflux Mechanism in Monolayers of a Human Intestinal Cell Line (Caco-2). Pharmaceutical Research. 18(8). 1110–1118. 12 indexed citations
4.
Steinmetzer, Torsten, Jörg Hauptmann, & Jörg Stürzebecher. (2001). Advances in the development of thrombin inhibitors. Expert Opinion on Investigational Drugs. 10(5). 845–864. 57 indexed citations
5.
Steinmetzer, Torsten, et al.. (2000). New Bivalent Thrombin Inhibitors with N? (Methyl)Arginine at the P1-Position. Biological Chemistry. 381(7). 603–10. 8 indexed citations
6.
Hauptmann, Jörg & Jörg Stürzebecher. (1999). Synthetic Inhibitors of Thrombin and Factor Xa. Thrombosis Research. 93(5). 203–241. 113 indexed citations
7.
Steinmetzer, Torsten, Martin Renatus, A. Eichinger, et al.. (1999). Design and evaluation of novel bivalent thrombin inhibitors based on amidinophenylalanines. European Journal of Biochemistry. 265(2). 598–605. 21 indexed citations
9.
Stubbs, Milton T., Andreas Bergner, Jörg Hauptmann, et al.. (1998). Design of Benzamidine-Type Inhibitors of Factor Xa. Journal of Medicinal Chemistry. 41(22). 4240–4250. 33 indexed citations
10.
Stürzebecher, Jörg, et al.. (1997). Synthesis and Structure−Activity Relationships of Potent Thrombin Inhibitors:  Piperazides of 3-Amidinophenylalanine. Journal of Medicinal Chemistry. 40(19). 3091–3099. 88 indexed citations
11.
Kaiser, Brigitte & Jörg Hauptmann. (1994). Factor Xa Inhibitors as Novel Antithrombotic Agents: Facts and Perspectives. Cardiovascular Drug Reviews. 12(3). 225–236. 25 indexed citations
12.
Kaiser, Brigitte & Jörg Hauptmann. (1992). Pharmacology of Synthetic Thrombin Inhibitors of the Tripeptide Type. Cardiovascular Drug Reviews. 10(1). 71–87. 23 indexed citations
13.
Hauptmann, Jörg & F Markwárdt. (1977). Inhibition of the haemolytic complement activity by derivatives of benzamidine. Biochemical Pharmacology. 26(4). 325–329. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026